CompletedNot Applicable

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

United States25 participantsStarted 2006-01

Plain-language summary

RATIONALE: Measuring levels of transforming growth factor-beta (TGF-beta) in the blood of patients with epithelial cancers (head and neck, lung, breast, colorectal, and prostate) may help doctors predict how patients will respond to treatment with radiation therapy. PURPOSE: This research study is measuring levels of TGF-beta in patients with epithelial cancers who are undergoing radiation therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Known diagnosis of an epithelial cancer, including any of the following: * Head and neck * Lung * Breast * Colorectal * Prostate * Radiotherapy must be a component of planned treatment therapy PATIENT CHARACTERISTICS: * No serious medical or psychiatric illnesses which would prevent informed consent

What they're measuring

TGF-beta levels

Timeframe: day 1 prior to treatment, 24-72 hours after 1st treatment, weekly at treatment (optional) and at completion of treatment

Trial details

NCT IDNCT00897793

SponsorVanderbilt-Ingram Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-07

View on ClinicalTrials.gov More Breast Cancer trials